Breast-Cancer Pill Reduced Recurrence, Death in Early-Stage Patients, Study Finds

A drug sold by AstraZeneca and Merck reduced the recurrence of breast cancer in women with an early but aggressive form of the disease, a long-running international study found.

Jump To The Original Source

Share this Story
Load More Related Articles
Load More In US News

Facebook Comments

Check Also

Pope hosts visit by 20 inmates in Vatican home

Published by DPA Pope Francis hosted about 20 ...

Archives